Literature DB >> 15175388

Identification of motifs involved in endoplasmic reticulum retention-forward trafficking of the GLT-1 subtype of glutamate transporter.

Avtandil Kalandadze1, Ying Wu, Keith Fournier, Michael B Robinson.   

Abstract

Glutamate transporters may exist as homomultimers, but little is known about the mechanisms that ensure proper assembly and surface expression. In the present study, we investigated the mechanisms that contribute to posttranslational processing of the GLT-1 subtype of glutamate transporter. An extracellular leucine-based motif was identified that after mutation to alanine (6L/6A GLT-1) prevented export of GLT-1 from the endoplasmic reticulum (ER) to the plasma membrane and displayed a glycosylation pattern characteristic of "immature" transporter. This 6L/6A variant had a selective dominant-negative effect on wild-type GLT-1 expression and formed coimmunoprecipitable complexes with GLT-1. Mutation of two downstream arginine residues to alanine partially restored maturation and functional activity of the 6L/6A variant. The fact that this additional mutation rescued maturation of GLT-1 essentially excludes the possibility that the 6L/6A mutant variant is not appropriately processed because of simple misfolding. When the domain containing these motifs was introduced into a topologically similar location in the interleukin 2alpha receptor subunit (Tac protein), the mutations had a similar effect on protein maturation. Topological models place at least the leucine-based motif in an extracellular domain, which would face the lumen of the ER during assembly. On the basis of these data, we suggest that an evolutionarily conserved arginine-based motif functions as an ER retention signal and a lumenal leucine motif is required for suppression of this signal. Interestingly, a high percentage of variably spliced GLT-1 mRNAs lacking parts of this domain are found in the CNS, suggesting that GLT-1 expression may be regulated during assembly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175388      PMCID: PMC6729204          DOI: 10.1523/JNEUROSCI.0839-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  21 in total

1.  Multiple sequences in the C terminus of MaxiK channels are involved in expression, movement to the cell surface, and apical localization.

Authors:  Sang-Ho Kwon; William B Guggino
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-05       Impact factor: 11.205

2.  Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes.

Authors:  Geraldine T Petr; Yan Sun; Natalie M Frederick; Yun Zhou; Sameer C Dhamne; Mustafa Q Hameed; Clive Miranda; Edward A Bedoya; Kathryn D Fischer; Wencke Armsen; Jianlin Wang; Niels C Danbolt; Alexander Rotenberg; Chiye J Aoki; Paul A Rosenberg
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

3.  An aberrant sequence in a connexin46 mutant underlies congenital cataracts.

Authors:  Peter J Minogue; Xiaoqin Liu; Lisa Ebihara; Eric C Beyer; Viviana M Berthoud
Journal:  J Biol Chem       Date:  2005-10-03       Impact factor: 5.157

4.  Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia.

Authors:  Dan Shan; Daniel Mount; Stephen Moore; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2014-02-21       Impact factor: 4.939

5.  Multiple evolutionarily conserved Di-leucine like motifs in the carboxyl terminus control the anterograde trafficking of NKCC2.

Authors:  Nancy Zaarour; Sylvie Demaretz; Nadia Defontaine; Yingying Zhu; Kamel Laghmani
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

6.  Exon-skipping splice variants of excitatory amino acid transporter-2 (EAAT2) form heteromeric complexes with full-length EAAT2.

Authors:  Florian M Gebhardt; Ann D Mitrovic; Daniel F Gilbert; Robert J Vandenberg; Joseph W Lynch; Peter R Dodd
Journal:  J Biol Chem       Date:  2010-08-05       Impact factor: 5.157

Review 7.  The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.

Authors:  Edward Pajarillo; Asha Rizor; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  Neuropharmacology       Date:  2019-03-06       Impact factor: 5.250

Review 8.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

9.  Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia.

Authors:  Deborah Bauer; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2009-08-27       Impact factor: 4.939

10.  Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1.

Authors:  Yiting Liu; Svetlana Vidensky; Alicia M Ruggiero; Susanne Maier; Harald H Sitte; Jeffrey D Rothstein
Journal:  J Biol Chem       Date:  2007-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.